Pityriasis rubra pilaris treated with excimer lamp)
DOI:
https://doi.org/10.51481/amc.v62i3.1080Keywords:
excimer lamp, pitiriasis rubra pilaris (PRP), Lymphoma, T-Cell, Cutaneous type Mycosis Fungoides tipo micosis - Virus de inmunodeficiencia humana (VIH)Abstract
Pityriasis Rubra Pilaris is an inflammatory papulosquamous and hyperkeratic dermatosis of unknown cause and chronic progression which can envolve even into erythroderma. This case deals with a 27-year old male patient carrier of VIH who was diagnosed with PRP type IV. Initially, it was treated with topical corticosteroid and phototherapy for four months. However, it showed reactivation of the injuries; therefore, excimer lamp was employed, which is used in other dermatologic pathologies but it is not a regular treatment for PRP type IV.
Downloads
References
Annette Klein, Michael Landthaler and Sigrid Karrer. Pityriasis Rubra Pilaris. Am. J. Clin. Dermatol. 2010; 11:157-170.
Angélica Beirana Palencia, Tere Ivette Villanueva Ramos. Pitiriasis rubra pilaris: aspectos epidemiológicos y clínicos de 44 casos. Dermatol Rev Mex. 2008;52:153-159.
D. Velázquez, M. Valdivielso, C. Silvente, C. Eguren, J.M. Hernanz. Pitiriasis «rubra pilaris» localizada. Acta Pediatr Esp. 2012; 70:332-334.
Carvajal Carolina, Acosta Agustina, Álvarez Mariela. Pitiriasis rubra pilaris atípica en pediatría. A propósito de un caso. Arch. Pediatr. Urug. 2017;5:279-283
Nicholas A. Ross, Hye-Jin Chung, Qiaoli Li, Jonathan P. Andrews, Matthew S. Keller, Jouni Uitto Epidemiologic, Clinicopathologic, Diagnostic and Management Challenges of Pityriasis Rubra Pilaris. JAMA Dermatol. 2016; 152:670-675.
Sehgal VN, Srivastava G, Dogra S. Adult onset pityriasis rubra pilaris. Indian J Dermatol Venereol Leprol 2008; 74:311-321.
Mark D. Heibel, and Haley D. Heibel. Successful treatment of type I pityriasis rubra pilaris with ixekizumab. Am Acad. Dermatol. 2018; 4:774-776.
Lamotte Castillo José Antonio. Infección por VIH/sida en el mundo actual. MEDISAN, 2014; 18:993-1013.
Peter Haeusermann, Katja Ivanova Peter Itin. Pityriasis Rubra Pilaris: Treatment with Biologics -A New Promising Therapy Dermatology. 2012; 224:120-125.
Massa AF, Vasconcelos P, de Almeida LS, Filipe P. Pityriasis rubra pilaris mixed type III/IV successfully treated with narrow band-ultraviolet B. Indian J Dermatol Venereol Leprol. 2015; 81:435.
Dipankar De, Sunil Dogra, DNB y Tarun Narang, Bishan Dass Radotra. Pityriasis Rubra Pilaris in a HIV-Positive Patient (Type 6 PRP).SKINmed. 2008; 7:47-50.
Michael Abrouk, Ethan Levin, Merrick Brodsky, Jessica R Gandy, Mio Nakamura, Tian Hao Zhu et al Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability. 2016; 6:165-173.
Consuelo Apagüeño, Fredy Pajares, Patricia Cardoza, César Gonzales, Maritza Hipólito. Pitiriasis rubra pilaris clásica juvenil: reporte de un caso. Folia dermatol. Peru. 2012; 23:87-92.
Elsa Maira P., Ana María Kutz E., Alex Castro M. Pitiriasis Rubra Pilaris eritrodérmica: Algo para no olvidar. Rev. Chilena Dermatol. 2012; 29:167- 172.
María Isabel García Briz, Ramón García Ruiz, Ana Isabel Zayas Gávila, Almudena Mateu Puchades
Pitiriasis rubra pilaris. ¿Algo más que un trastorno de la queratinización? Med Cutan Iber Lat Am. 2018; 46:7-12.
Gastón Galimberti, Damián Ferrario, Daniel Galimberti, Ricardo Luis Galimberti, Camila Giusti, Florencia Rodríguez Chiapetta. Excimer excilite. Avance en la utilización de luz monocromática de 308 nm en Dermatología. Med Cutan Iber Lat Am. 2006; 34:99-108
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
